Biotech · Private company · New York, NY, US

Nirsum Laboratories, Inc.

Track this companyFree. Adds Nirsum Laboratories, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use DisorderFiscal year 2026 · $4.9MNIH RePORTER 5U01DA061643-03 · fetched Nov 12, 2026
Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use DisorderFiscal year 2025 · $4.9MNIH RePORTER 5U01DA061643-02 · fetched Nov 12, 2026
Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use DisorderFiscal year 2024 · $4.8MNIH RePORTER 1U01DA061643-01 · fetched Nov 12, 2026
Development of a novel drug for treating opioid use disorderFiscal year 2024 · $3.1MNIH RePORTER 5UH3DA048234-05 · fetched Nov 12, 2026